Nucleic acid construct with gene encoding an arabinofuranosidase polypeptide and methods of using same

US9428741B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9428741-B2
Application numberUS-201514680942-A
CountryUS
Kind codeB2
Filing dateApr 7, 2015
Priority dateApr 26, 2005
Publication dateAug 30, 2016
Grant dateAug 30, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides, such that the nucleic acid is operably linked to a heterologous control sequence for expression. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides set forth in SEQ ID NO: 2 and fragments of SEQ ID NO: 2.

First claim

Opening claim text (preview).

The invention claimed is: 1. A nucleic acid construct comprising a nucleic acid sequence encoding a polypeptide having arabinofuranosidase activity, wherein the nucleic acid sequence is operably linked to one or more heterologous control sequences capable of directing the expression of the polypeptide in a suitable expression host, and wherein the polypeptide is selected from the group consisting of: (a) a polypeptide with at least 95% sequence identity to the mature polypeptide of SEQ ID NO: 2; and (b) a polypeptide which is encoded by a nucleic acid sequence which hybridizes under high stringency conditions with the full complement of the nucleic acid sequence of nucleotides 55-1677 of SEQ ID NO: 1; wherein the high stringency conditions are defined as prehybridization and hybridization at 42° C. in 5×SSPE, 0.3% SDS, 200 micrograms/mL sheared and denatured salmon sperm DNA, and 50% formamide for high stringency, following standard Southern blotting procedures, followed by washing three times each for 15 minutes using 2×SSC, 0.2% SDS at 65° C. 2. The nucleic acid construct of claim 1 , wherein the polypeptide has at least 95% sequence identity to the mature polypeptide of SEQ ID NO: 2. 3. The nucleic acid construct of claim 1 , wherein the polypeptide has at least 97% sequence identity to the mature polypeptide of SEQ ID NO: 2. 4. The nucleic acid construct of claim 1 , wherein the polypeptide comprises the mature polypeptide of SEQ ID NO: 2. 5. The nucleic acid construct of claim 1 , wherein the polypeptide is a fragment of the mature polypeptide of SEQ ID NO: 2 and has arabinofuranosidase (EC 3.2.1.55) activity, wherein the fragment has one or more amino acids deleted from the amino and/or carboxyl terminus of the mature polypeptide of SEQ ID NO: 2 and has at least 430 amino acids of the mature polypeptide of SEQ ID NO: 2. 6. The nucleic acid construct of claim 1 , wherein the polypeptide is native to a strain of Humicola. 7. The nucleic acid construct of claim 1 , wherein the polypeptide is native to a strain of Humicola insolens. 8. The nucleic acid construct of claim 1 , wherein the polypeptide comprises amino acids 19 to 558 of SEQ ID NO: 2 and exhibits arabinofuranosidase activity. 9. A recombinant expression vector comprising the nucleic acid construct of claim 1 . 10. A recombinant host cell transformed with the nucleic acid construct of claim 1 . 11. A method for producing a polypeptide having arabinofuranosidase activity, comprising cultivating the recombinant host cell of claim 10 under conditions conducive for production of the polypeptide, and recovering the polypeptide. 12. A recombinant host cell transformed with a nucleic acid sequence encoding a polypeptide having arabinofuranosidase activity, wherein the nucleic acid sequence is operably linked to one or more heterologous control sequences and wherein the polypeptide is selected from the group consisting of: (a) a polypeptide with at least 95% sequence identity to the mature polypeptide of SEQ ID NO: 2; and (b) a polypeptide which is encoded by a nucleic acid sequence which hybridizes under high stringency conditions with the full complement of the nucleic acid sequence of nucleotides 55-1677 of SEQ ID NO: 1; wherein the high stringency conditions are defined as prehybridization and hybridization at 42° C. in 5×SSPE, 0.3% SDS, 200 micrograms/mL sheared and denatured salmon sperm DNA, and 50% formamide for high stringency, following standard Southern blotting procedures, followed by washing three times each for 15 minutes using 2×SSC, 0.2% SDS at 65° C. 13. A method for producing a polypeptide having arabinofuranosidase activity, comprising cultivating the recombinant host cell of claim 12 under conditions conducive for production of the polypeptide, and recovering the polypeptide.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9428741B2 cover?
The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides, such that the nucleic acid is operably linked to a heterologous control sequence for expression. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods fo…
Who is the assignee on this patent?
Novozymes As
What technology area does this patent fall under?
Primary CPC classification C12N9/2402. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).